Search | Site Info | Site Map

MENU

HOMEPAGE

Animal Health/
Welfare/Zoonoses

Environment

Land Reform

Social/
Economic/
Political

Food

Science

Fishing

Tourism

Education

Cultybraggan
Farm

Trade

Book Reviews

Light Relief

Links

Glossary

Correspondence

Vacancies

Contact Us

Get Acrobat Reader

 

 

Back to Science Homepage

21 March 2003

Where has UK Biotechnology gone?

James Irvine

FRSE, DSc, FRCP(Ed), FRCPath, FInstBiol, FIsntDirectors

Teviot Scientific Consultancy, Edinburgh
Teviot Agriculture, Cultybraggan Farm, Comrie, Perthshire
Scotland

Filed 21 March 2003

 

When researching information on what tests for BSE are available and currently in extensive use on the Continent of Europe, and which could potentially be used routinely in the UK according to recent statements by the FSA (1), it was depressing to find that of the four commercial tests selected for evaluation (2, 3, 4) the one that was eliminated was from the UK.

The tests in kit form that were approved by the EC are in alphabetical order:

Commissariat à l’Energie Atomique (France)
Enfer Technology Ltd (Ireland)
Prionics A.G. (Switzerland)

The exclusion of the UK application was perfectly fair and open (3). It simply did not meet the specification requirements (3).

One hears so much about the need for UK academic research to integrate with commerce, and we hear so much about how great our academic institutions are - so how come we cannot compete effectively, even in relation to a disease that has caused so much devastation to human health (actual and potential cases of vCJD), animal welfare (BSE in cattle and its theoretical potential presence in sheep) and to the livestock trade in our country?

The question has to be asked whether or not there was effective co-operation between our Academic Research Institutions and the commercial company trying to make an effective bid for this highly lucrative market.

If the FSA proposals to scrap or modify the OTMS come into effect (5), and if the new scheme involves routine post-mortem testing of all UK cattle over a certain age using these tests, the UK will have to buy these diagnostic kits from our neighbours in Europe. Even more of our financial resources will go out of the country. The outcome will be that the UK suffers most from the disease, while others reap the benefits of the science that has been applied to it.

One cannot help thinking back to the Royal Society of Edinburgh FMD Inquiry (6) where evidence was submitted from within the UK (7) and abroad (8) that UK Research Institutions were less than accommodating in terms of the development of what they allegedly regarded as rival commercial interests.

On page 14 para 62 of the RSE FMD Inquiry (6) reference is made to the need, as a matter of the highest priority, for collaboration with interested commercial companies in relation to the development of appropriate tests. It is to be wondered as to whether or not this principle also applied to BSE.

 

References

1. Irvine, James (2003). Food Standards Agency Review of OTMS: a follow up
(Filed 20 March 2003, www.land-care.org.uk, click here to view).

2. European Commission (1999). Preliminary Report: The Evaluation of tests for the diagnosis of transmissible spongiform encephalopathy in bovines. 8 July 1999. (Download PDF).

3. Moynagh J. & Schimmel, H. (1999). Tests for BSE evaluated. Nature, 400: 105. (Download PDF). Reproduced with permission.

4. Butler, D. (1998). Brussels seeks BSE diagnostic test to screen European cattle. Nature, 395: 205. (Download PDF). Reproduced with permission.

5. Irvine, James (2003). The Food Standards Agency reviews the OTMS rule - are they going to scrap it?
(Filed 12 March 2003, www.land-care.org.uk, click here to view).

6. Royal Society of Edinburgh (2002). Inquiry into Foot and Mouth Disease in Scotland. July 2002. (Download PDF).

7. Fink, Colin G (Micropathology Ltd) (2002). Evidence Submitted to the Royal Society of Edinburgh Inquiry, January 2002. (Download PDF).

8. Walfield, Alan M (United Biomedical Inc) (2002). Evidence Submitted to the Royal Society of Edinburgh Inquiry, January 2002. (Download PDF).

 

Further Reading Recommended by Land-Care

Irvine, James (2003). Current Assessment of the Future Prevalence of vCJD in the UK.
(Filed 12 March 2003, www.land-care.org.uk, click here to view).

Detection of Prions: Developing Technology
(Filed 12 March 2003, www.land-care.org.uk, click here to view).